Related Experiment Video
Updated: Jun 8, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Diarrhea Predominant Irritable Bowel Syndrome (IBS-D): fact or fiction
1Overlook Hospital - Atlantic Health System, NJ, USA. HabbaMD@gmail.com
Abstract:
Diarrhea Predominant Irritable Bowel Syndrome IBS (IBS-D) and functional diarrhea constitute 50% of cases treated by gastroenterology specialists and a significant proportion of those treated in a primary physicians practice. The size of the problem and the difficulty in successfully addressing these entities has frustrated patients and physicians alike. The presented data delineates work-up, final diagnoses and clinical outcomes in the largest single clinical retrospective study of 303 patients with an initial presentation of IBS-D and functional diarrhea. Results indicate that 298 (98%) patients were found to have a diagnosis different from the initial presentation of IBS-D, and 204 (68%) of the patients studied had conditions related to treatable bile acid abnormalities. After identifying these clinical diagnoses and instituting appropriate therapy, 98% of these patients had a favorable response, as measured by a decrease in the number of bowel movements to less than three per day and a significant change in the consistency of the stools. This finding is dramatically different from the poor response generally experienced from conventional therapy for IBS-D and functional chronic diarrhea. The data presented in this study substantiates the hypothesis that IBS-D and functional diarrhea do not exist as true clinical entities and explains the previous lack of satisfactory therapeutic response. Symptoms experienced by these patients were caused by a collection of different clinical conditions bunched up under this "umbrella" diagnosis of IBS-D. Once these separate entities were identified and appropriately addressed, the clinical response was quite impressive and encouraging. The implication of this hypothesis could be of vital importance because of the number of those suffering from these symptoms.
Related Concept Videos
Irritable Bowel Syndrome
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

